1/26
A comprehensive set of practice flashcards covering the biochemistry of purine and pyrimidine nucleotides, including their structure, synthesis (de novo and salvage), catabolism, associated clinical disorders, and pharmacological inhibitors.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Nucleotide
A molecule composed of a sugar, a nitrogenous base, and a phosphate group.
Nucleoside
A molecule composed of a sugar and a nitrogenous base, lacking a phosphate group.
Purines
Nitrogenous bases featuring a double-ring structure (six-membered pyrimidine ring fused to a five-membered imidazole ring), including Adenine (A) and Guanine (G).
Pyrimidines
Nitrogenous bases featuring a single six-membered ring structure, including Cytosine (C), Thymine (T), and Uracil (U).
Complementary Base Pairing
The specific pairing of nitrogenous bases where Adenine pairs with Thymine (or Uracil in RNA) via 2 hydrogen bonds, and Guanine pairs with Cytosine via 3 hydrogen bonds.
Phosphodiester Bond
The bond that connects the 5′−OH group of one nucleotide to the 3′−OH group of another via a phosphate group, forming the backbone of DNA and RNA.
Endonucleases
Enzymes that create adhesive ends by cutting phosphodiester bonds within the middle of a DNA sequence.
Exonucleases
Enzymes that remove a single nucleotide from the terminal end of a DNA chain.
Dactinomycin
A drug that enters the grooves of the DNA double helix and disrupts DNA synthesis.
DNA Helix Dimensions
A single turn of the double helix contains 10 base pairs, covering a distance of 3.4nm, with a helix width of 2nm and a distance between bases of 11Angstroms. (1nm=10Angstroms or 10−9m).
Nucleosome
The structural unit of eukaryotic organization consisting of DNA tightly bound to histone proteins (Histone+DNA).
Histones
Proteins rich in arginine and low in lysine that organize DNA; types include H1 (species-specific), H2A, H2B, H3, and H4.
Purine Ring Atom Origins
N3 and N9 from glutamine; N1 from aspartate; N7, C4, and C5 from glycine; C2 and C8 from tetrahydrofolate (THF); and C6 from CO2.
PRPP (5-phosphoribosyl 1-pyrophosphate)
An active sugar intermediate required for both de novo and salvage pathways of nucleotide synthesis, formed from Ribose 5-Phosphate and ATP by PRPP synthetase.
IMP (Inosine Monophosphate)
The first intermediate in de novo purine synthesis that contains a complete purine ring; it serves as the precursor for both AMP and GMP.
Salvage Pathway
A process in which free purine bases (adenine, guanine, hypoxanthine) released from nucleic acid breakdown are recycled back into nucleotides using enzymes like APRT and HGPRT.
Lesch-Nyhan Syndrome
An X-linked recessive disorder caused by a deficiency of the enzyme HGPRT, leading to hyperuricemia, neurological symptoms (self-mutilation, mental retardation), and increased de novo purine synthesis.
Uric Acid
The final product of purine catabolism in humans.
Xanthine Oxidase
The enzyme responsible for converting hypoxanthine to xanthine and xanthine to uric acid, requiring FAD, iron (Fe), sulfur (S), and molybdenum (Mo) as cofactors.
Von Gierke Disease (Glycogen Storage Disease Type 1)
An autosomal recessive deficiency of glucose 6-phosphatase that leads to an accumulation of Glucose 6-phosphate, accelerating the pentose phosphate pathway and increasing purine synthesis, resulting in hyperuricemia.
Carbamoyl Phosphate Synthetase II (CPS II)
A cytosolic enzyme that catalyzes the rate-limiting step of de novo pyrimidine synthesis in eukaryotes (Glutamine+CO2+2ATP→Carbamoylphosphate); inhibited by UTP and activated by ATP and PRPP.
Dihydroorotate Dehydrogenase
A mitochondrial enzyme that oxidizes dihydroorotate to orotic acid; distinct as most other pyrimidine synthesis enzymes are cytosolic.
Ribonucleotide Reductase
The rate-limiting enzyme that converts ribonucleotides to deoxyribonucleotides by reducing them at the 2′ carbon; requires thioredoxin as a cofactor and is inhibited by hydroxyurea and dATP.
Thymidylate Synthase
The enzyme that converts dUMP to dTMP using N5,N10-methylene tetrahydrofolate as a methyl donor; inhibited by 5−fluorouracil.
Orotic Aciduria
An autosomal recessive condition caused by a deficiency in orotate phosphoribosyl transferase or OMP decarboxylase, characterized by growth retardation and severe megaloblastic anemia that does not respond to iron or B vitamins; treated with uridine or cytidine.
Beta-Alanine
The degradation product of the pyrimidines Cytosine and Uracil.
Beta-Aminoisobutyrate
The degradation product of the pyrimidine Thymine.